Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 29;15(1):6390.
doi: 10.1038/s41467-024-50807-x.

Harnessing intestinal tryptophan catabolism to relieve atherosclerosis in mice

Affiliations

Harnessing intestinal tryptophan catabolism to relieve atherosclerosis in mice

Mouna Chajadine et al. Nat Commun. .

Abstract

Tryptophan (Trp) is an essential amino acid, whose metabolism is a key gatekeeper of intestinal homeostasis. Yet, its systemic effects, particularly on atherosclerosis, remain unknown. Here we show that high-fat diet (HFD) increases the activity of intestinal indoleamine 2, 3-dioxygenase 1 (IDO), which shifts Trp metabolism from the production of microbiota-derived indole metabolites towards kynurenine production. Under HFD, the specific deletion of IDO in intestinal epithelial cells leads to intestinal inflammation, impaired intestinal barrier, augmented lesional T lymphocytes and atherosclerosis. This is associated with an increase in serotonin production and a decrease in indole metabolites, thus hijacking Trp for the serotonin pathway. Inhibition of intestinal serotonin production or supplementation with indole derivatives alleviates plaque inflammation and atherosclerosis. In summary, we uncover a pivotal role of intestinal IDO in the fine-tuning of Trp metabolism with systemic effects on atherosclerosis, paving the way for new therapeutic strategies to relieve gut-associated inflammatory diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Induction of IEC IDO by HFD has a protective role in atherosclerosis.
A Tryptophan (Trp), Kynurenine (Kyn) levels, and related Kyn/Trp ratio (%) in the small intestine extracts (n = 5 mice/group), B plasma indole levels in the portal vein, C. 5-hydroxytryptamine (5-HT) in the small intestine extracts of male Ldlr−/− mice fed either normal chow diet (NCD), high-fat diet (HFD), or high-cholesterol diet (HCD) or the combination of both HFD + HCD for 13 weeks (n = 5 mice/group). D Kyn levels in feces of Ldlr−/− mice fed HFD supplemented or not with FOS for 13 weeks (n = 5 mice/group). E, F Kyn/Trp ratio (%) in the small intestine extracts and plasma in male Ldlr−/− IEC IDO KO and littermate control Ldlr−/− IEC IDO mice (n = 5 mice/group), after 8 weeks of HFD + HCD or NCD feeding period. NCD represents the control group without atherosclerosis development. G. Plasma cholesterol, H representative pictures, and quantifications of plaque size in the aortic sinus in male Ldlr−/− IEC IDO KO (n = 12 mice) and littermate control Ldlr−/− IEC IDO (n = 12 mice) fed HFD + HCD for 8 weeks; scale bar 200 µm. I Plasma cholesterol, J representative pictures and quantifications of plaque size in the aortic sinus in female Ldlr−/− IEC IDO KO (n = 9 mice), and littermate controls Ldlr−/− IEC IDO (n = 9 mice) fed HFD + HCD for 13 weeks; scale bar 200 µm. Individual data are presented as scattered dot plots, with the mean and s.e.m. The p values were determined using the Brown-Forsythe one-way ANOVA test followed by Tukey’s multiple comparison test. Source data are provided as a Source Data file.
Fig. 2
Fig. 2. Deficiency of IDO in intestinal epithelial cells (IECs) increases intestinal and plaque inflammation.
A fecal lipocalin 2 (Lcn2) levels scoring in male Ldlr−/− IEC IDO KO (n = 10 mice) and littermate control Ldlr−/− IEC IDO (n = 9 mice). B colon pathohistological scoring in male Ldlr−/− IEC IDO KO and littermate control Ldlr−/− IEC IDO mice (n = 10 mice/group), after 8 weeks of high-fat and high-cholesterol diet (HFD + HCD) feeding period; scale bar 100 µm. C Representative confocal microscopy pictures of microbiota localization: Mucin 2 (green), actin (purple), bacteria (red), and nuclei (blue) and quantifications of mean distances of the closest bacteria (in red) to colonic IEC per condition over three high-powered fields per mouse (IEC IDO n = 10 mice, IEC IDOKO n = 7 mice); scale bar 100 µm. D data were acquired by flow cytometry for Uniform Manifold Approximation and Projection (UMAP) of lymphocytes in the lamina propria of the small intestines. E plasma anti-LPS IgG by ELISA, arbitrary units (arb. units). The results are from male Ldlr−/− IEC IDO KO (n = 11 mice) and littermate control Ldlr−/− IEC IDO mice (n = 13 mice) fed HFD + HCD for 8 weeks. F Detection by ELISA of FITC-dextran in serum of female Ldlr−/− IEC IDO KO (n = 8 mice) and littermate control Ldlr−/− IEC IDO (n = 9 mice) fed HFD + HCD for 13 weeks. G Representative photomicrographs and quantitative analysis of lesional T cells (CD3+ in red) accumulation in the aortic sinus of male Ldlr−/− IEC IDO KO (n = 9 mice) and littermate control Ldlr−/− IEC IDO (n = 10 mice), after 8 weeks of HFD + HCD feeding period; scale bar 100 µm. H plasma cholesterol, I. representative pictures, and quantifications of plaque size in the aortic sinus in male Ldlr−/−Rag1−/− IEC IDO KO (n = 9 mice) and littermate control Ldlr−/−Rag1−/− IEC IDO (n = 11 mice) fed HFD + HCD for 8 weeks; scale bar 200 µm. Individual data are presented as scattered dot plots, with the mean and s.e.m. The p values were determined using the two-tailed Mann-Whitney test. Source data are provided as a Source Data file.
Fig. 3
Fig. 3. Intestinal 5-hydroxytryptamine (5-HT) exhibits pro-inflammatory and pro-atherogenic effects.
A 5-HT levels in small intestine extracts (n = 5 mice/group), B plaque quantification in the aortic sinus and representative images of male Ldlr−/− treated with Tryptophan Hydroxylase 1 (TPH1) inhibitor (LP533401, n = 6 mice) or vehicle (n = 8 mice) and fed HFD + HCD for 8 weeks; scale bar 200 µm. C, D representative images and quantifications of macrophages (MOMA-2+ in red) and lymphocytes (CD3+ in red) accumulation in the aortic sinus (Ldlr−/− Vehicle n = 8, Ldlr−/− LP533401 n = 6); scale bar 100 µm. E representative pictures and quantifications of plaque size in the aortic sinus male Ldlr−/− IEC IDO KO and littermate control Ldlr−/− IEC IDO mice treated with either LP533401 or vehicle and fed HFD + HCD for 8 weeks (IEC IDO Vehicle n = 11 mice, IEC IDO KO Vehicle n = 7 mice, IEC IDO LP533401 n = 11 mice, IEC IDO KO LP533401 n = 9 mice); scale bar 200 µm. F Colon pathohistological scoring (IEC IDO Vehicle n = 5 mice, IEC IDO KO Vehicle n = 10 mice, IEC IDO LP533401 n = 5 mice, IEC IDO KO LP533401 n = 10 mice). G lipocalin-2 (Lcn2) levels in feces (IEC IDO Vehicle n = 5 mice, IEC IDO KO Vehicle n = 7 mice, IEC IDO LP533401 n = 5 mice, IEC IDO KO LP533401 n = 10 mice). Individual data are presented as scattered dot plots, with the mean and s.e.m. The p values were determined using the two-tailed Mann-Whitney test for AD, Kruskal-Wallis, followed by post-Hoc Dunn’s test for F, and one-way ANOVA test followed by Tukey’s multiple comparison test for E and G. Source data are provided as a Source Data file.
Fig. 4
Fig. 4. Trp-dependent microbiota effects impact atherosclerosis.
A Plasma cholesterol, B representative pictures and quantifications of plaques in the aortic sinus of male Ldlr−/− IEC IDO KO and littermate control Ldlr−/− IEC IDO mice treated with antibiotics (ATB) during the 8 weeks of high-fat and high-cholesterol diet (HFD + HCD) feeding period (IEC IDO ATB n = 12 mice, IEC IDO KO ATB n = 11 mice); scale bar 200 µm. C plaque quantification in the aortic sinus of male Ldlr−/− IEC IDO KO and littermate control Ldlr−/− IEC IDO mice either separated by the genotype or mixed (co-housing) in the same cages from the weaning. The mice were fed HFD + HCD for 8 weeks (IEC IDO n = 8 mice, IEC IDO KO n = 7 mice, IEC IDO co-housing n = 8 mice, and IEC IDO KO co-housing n = 8 mice). D colon pathohistological scoring; scale bar 100 µm, E plasma cholesterol levels, F representative pictures and quantifications of plaque size in the aortic sinus; scale bar 200 µm, G representative pictures and quantifications of lymphocytes (CD3+ in red) accumulation within plaques in the aortic sinus of male Ldlr−/−mice treated with 6-Formylindolo(3,2-b)carbazole (Ficz) or vehicle; scale bar 100 µm (n = 8 mice/group) during the 8 weeks of HCD feeding period. Individual data are presented as scattered dot plots, with the mean and s.e.m. The p values were determined using the two-tailed Mann-Whitney test. Source data are provided as a Source Data file.
Fig. 5
Fig. 5. Indole derivatives alleviate inflammation and atherosclerosis.
A indole derivatives (sum of IAA, IPA, and tryptamine) levels supplemented or not in female Ldlr−/− mice fed a high-cholesterol diet (HCD) for 8 weeks (n = 10 mice/group). B data were acquired by flow cytometry for Uniform Manifold Approximation and Projection (UMAP) of leukocytes in the lamina propria of small intestines. Unbiased multi-dimensional analysis by X-shift revealed several different clusters. C plasma cholesterol levels, D representative pictures and plaque size quantification in the aortic sinus; scale bar 200 µm, E representative images and lipid quantification with en-face staining in the thoracic aorta (n = 10 mice/group); scale bar 2 mm, F representative photomicrographs and quantitative analysis of lesional macrophages (MOMA2+ in red) accumulation in the aortic sinus of female Ldlr−/− mice fed HCD for 8 weeks (Ldlr−/− Vehicle n = 9 mice, Ldlr−/− Indole n = 10 mice); scale bar 100 µm. Individual data are presented as scattered dot plots, with the mean and s.e.m. The p values were determined using the two-tailed Mann-Whitney test. Source data are provided as a Source Data file.

References

    1. Cainzos-Achirica, M. et al. Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week. J. Am. Coll. Cardiol.76, 2895–2905 (2020). 10.1016/j.jacc.2020.10.027 - DOI - PubMed
    1. Witkowski, M., Weeks, T. L. & Hazen, S. L. Gut Microbiota and Cardiovascular Disease. Circ. Res127, 553–570 (2020). 10.1161/CIRCRESAHA.120.316242 - DOI - PMC - PubMed
    1. Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity39, 372–385 (2013). 10.1016/j.immuni.2013.08.003 - DOI - PubMed
    1. Gao, J. et al. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. Front. Cell. Infect. Microbiol.8, 13 (2018). 10.3389/fcimb.2018.00013 - DOI - PMC - PubMed
    1. Agus, A., Planchais, J. & Sokol, H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe23, 716–724 (2018). 10.1016/j.chom.2018.05.003 - DOI - PubMed

MeSH terms